Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.
Chiang HC, Lee YC, Chang TT, Lin YJ, Wu HT, Wang CT, Chen CY, Chen PJ, Hsieh MT, Lin SH, Chen SH, Chuang CH, Wu IC, Hong TC, Wu JS, Han MZ, Chen WT, Chiang CM, Hung KK, Kuo HY.
Chiang HC, et al. Among authors: chuang ch.
Cancers (Basel). 2023 Jan 30;15(3):854. doi: 10.3390/cancers15030854.
Cancers (Basel). 2023.
PMID: 36765812
Free PMC article.